ING THINK
China: the next Pfizer will be Chinese
From the original
CHINA: China has rapidly become a leading hub for new innovative medicines, overtaking Europe and nearing the US. The country has become an innovation engine particularly in therapeutic areas such as oncology, immunology, antibody–drug conjugates (ADCs), bispecifics and cell/gene
Related speeches
4 itemsMore from ING THINK
5 items- ING THINKMay 27, 2026
Rates Spark: Up and down with oil
- ING THINKMay 27, 2026
FX Daily: RBNZ joins the hawks
- ING THINKMay 27, 2026
The Commodities Feed: Oil falls as optimism builds over US‑Iran deal
- ING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future
- ING THINKMay 27, 2026
South Korea: Asia’s second innovation engine